Login / Register

Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Emergency & Urgent Care Providers
Emergency & Urgent Care Providers Emergency & Urgent Care Providers

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest


Emergency Care Conferences &
Educational Opportunities



Jan. 31 - Feb. 2

TAPA 2020 Annual CME Conference

Texas Academy of Physician Assistants

April 21 - 24

Atlanta CME Conference

Skin, Bones, Hearts & Private Parts

May 13 - 15

ANCC National Magnet Conference

American Nurses Credentialing Center

May 16 - 20

AAPA 2020 Conference

American Academy of PAs

June 9 - 12

Destin CME Conference

Skin, Bones, Hearts & Private Parts

More Events

Intranasal Sufentanil As Good As IV Morphine For Emergency Pain Relief, Study Finds | NEWS-Line for Emergency & Urgent Care Providers

Intranasal Sufentanil As Good As IV Morphine For Emergency Pain Relief, Study Finds


Source:

In patients presenting to an emergency department with severe traumatic pain, intranasal sufentanil was as good as standard-of-care intravenous morphine for pain relief, according to a new study published this week in PLOS Medicine by Marc Blancher of Grenoble Alpes University Hospital, France, and colleagues.

Intravenous morphine is the most commonly used strong analgesic for relieving acute pain in the emergency room, but the need to get an IV line started before administration limits its rapid use. In the new study, researchers randomized 136 patients who presented to the emergency departments of six hospitals across France.

Patients ranged in age from 18 to 75 years old and had traumatic pain self-evaluated as at least a six out of ten on a rating scale. 69 patients received intranasal sufentanil plus an intravenous placebo and 67 patients received intravenous morphine plus an intranasal placebo.

Patients' pain rating dropped by 4.1 points (97.5% CI -4.6 to -3.6) in the 30 minutes after analgesic administration in the group receiving intravenous morphine, and by 5.2 points (-5.7 to -4.6) with intranasal sufentanil. Intranasal sufentanil was shown to be non-inferior to intravenous morphine in terms of pain control at 30 minutes (p<0.001), as well as superior to morphine (p=0.034). 6 severe adverse events were observed in the intranasal sufentanil group and 2 in the intravenous morphine group, indicating that further research will be needed on the safety of intranasal sufentanil. Co-analgesics were used more often in the intranasal sufentanil group.

"The use of intranasal sufentanil might provide an easy and time saving solution in the management of acute pain," the authors say.

Source:PLOS

Photo Credit:ENGIN_AKYURT, PIXABAY






Share This!


Emergency Care Jobs



Respiratory

Baptist Health
Alabama

Medical Laboratory Scientist

Baptist Health
Alabama

Radiology

Baptist Health
Alabama

Full-Time RN/LPN & Part-Time RN/LPN

Chi St Alexius Health Garrison Hospital
Garrison, North Dakota

Ultrasound, Mammography and Radiologic Technologists

CareMount Medical, P.C
New York

Respiratory Care Practitioner- Sign on Bonus Eligible!

Froedtert Health - COMMUNITY MEMORIAL HOSPITAL
Menomonee Falls, Wisconsin

More Jobs
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.